{
  "paper_metadata": {
    "pmid": "35382848",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted BRCA2 variant information and penetrance data from ovarian cancer patients in South-East Poland."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.7007G>A",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 7,
        "affected_count": 7,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "A BRCA2 gene mutation was diagnosed in 7 (4.4%) unselected ovarian cancer cases."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": "Not specified.",
      "evidence_level": "Not specified.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No BRCA2 mutations were founder mutations.",
      "key_quotes": [
        "BRCA2 pathogenic variants were found in 7 of the 158 (4.4%) cases."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3975_3978dupTGCT",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 7,
        "affected_count": 7,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "BRCA2 mutation was diagnosed in 7 (4.4%) unselected ovarian cancer cases."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": "Not specified.",
      "evidence_level": "Not specified.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No BRCA2 mutations were founder mutations.",
      "key_quotes": [
        "BRCA2 pathogenic variants were found in 7 of the 158 (4.4%) cases."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5238dupT",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 7,
        "affected_count": 7,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "BRCA2 mutation was diagnosed in 7 (4.4%) unselected ovarian cancer cases."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": "Not specified.",
      "evidence_level": "Not specified.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No BRCA2 mutations were founder mutations.",
      "key_quotes": [
        "BRCA2 pathogenic variants were found in 7 of the 158 (4.4%) cases."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1384G>T",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 7,
        "affected_count": 7,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "BRCA2 mutation was diagnosed in 7 (4.4%) unselected ovarian cancer cases."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": "Not specified.",
      "evidence_level": "Not specified.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No BRCA2 mutations were founder mutations.",
      "key_quotes": [
        "BRCA2 pathogenic variants were found in 7 of the 158 (4.4%) cases."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.7615C>T",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 7,
        "affected_count": 7,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "BRCA2 mutation was diagnosed in 7 (4.4%) unselected ovarian cancer cases."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": "Not specified.",
      "evidence_level": "Not specified.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No BRCA2 mutations were founder mutations.",
      "key_quotes": [
        "BRCA2 pathogenic variants were found in 7 of the 158 (4.4%) cases."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.4544delA",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 7,
        "affected_count": 7,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "BRCA2 mutation was diagnosed in 7 (4.4%) unselected ovarian cancer cases."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": "Not specified.",
      "evidence_level": "Not specified.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No BRCA2 mutations were founder mutations.",
      "key_quotes": [
        "BRCA2 pathogenic variants were found in 7 of the 158 (4.4%) cases."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6267_6269delGCinsC",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 7,
        "affected_count": 7,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_7",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "BRCA2 mutation was diagnosed in 7 (4.4%) unselected ovarian cancer cases."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": "Not specified.",
      "evidence_level": "Not specified.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No BRCA2 mutations were founder mutations.",
      "key_quotes": [
        "BRCA2 pathogenic variants were found in 7 of the 158 (4.4%) cases."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "The frequency of founder mutations in unselected series of 158 ovarian cancer patients.",
      "variants_extracted": 7
    },
    {
      "table_name": "Table 2",
      "table_caption": "Prevalence of BRCA1 and BRCA2 mutations in ovarian cancer patients, by age of onset and family history.",
      "variants_extracted": 0
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 7,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All BRCA2 variants extracted were pathogenic and associated with ovarian cancer."
  }
}